Cargando…

A new era for medical liability in Italy: back to positivism

Detalles Bibliográficos
Autor principal:	Armocida, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2020
Materias:	E-Letters: Comments and Responses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927567/ https://www.ncbi.nlm.nih.gov/pubmed/33525306 http://dx.doi.org/10.23750/abm.v91i4.8478

Ejemplares similares

Care for others: the female perspective
por: Ciliberti, Rosagemma, et al.
Publicado: (2019)

Relief for the exhausted post-positivist: New epistemological choices transcend positivism, relativism, and even post-positivism
por: McMurtry, Angus
Publicado: (2020)

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)

Response to Comment on O’Connor et al. Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes. Diabetes Care 2014;37:3317–3324
por: O’Connor, Patrick J., et al.
Publicado: (2015)

Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S59
por: Herman, William H., et al.
Publicado: (2016)

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280
por: Bergenstal, Richard M., et al.
Publicado: (2019)

Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011. Diabetes Care 2016;39:363–370
por: Pathak, Ram D., et al.
Publicado: (2017)

Response to Comment on Dawson-Hughes et al. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916–2922
por: Dawson-Hughes, Bess, et al.
Publicado: (2021)

Logical positivism
Publicado: (1959)

Corona positiv!?
por: Distler, Ludwig
Publicado: (2021)

Response to Comment on Lewis et al. Management of Hemoglobin Variants Detected Incidentally in HbA(1c) Testing: A Common Problem Currently Lacking a Standard Approach. Diabetes Care 2017;40:e8–e9
por: Lewis, Michael R., et al.
Publicado: (2017)

COVID-19 vaccination surveillance: a public health commitment
por: Vigezzi, Giacomo Pietro, et al.
Publicado: (2021)

Conservative methotrexate treatment of a scar pregnancy case: adding evidence to the evidence
por: Ligorio, Claudia, et al.
Publicado: (2021)

Vaccination status as a criterion for prioritizing COVID-19 care; ethical or not ethical?
por: Ramphul, Kamleshun, et al.
Publicado: (2022)

Is direct per-oral pancreatoscopy a standardized technique for the diagnosis of pancreatic lesions? - Reply
por: Cortegoso Valdivia, Pablo, et al.
Publicado: (2021)

Commentary to the paper: A child of two mothers: what about the father? Italian overview
por: di luca, Alessandro
Publicado: (2021)

Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
por: Misra, Shivani, et al.
Publicado: (2020)

Response to Comment on Palmas et al. Results of the Northern Manhattan Diabetes Community Outreach Project: A Randomized Trial Studying a Community Health Worker Intervention to Improve Diabetes Care in Hispanic Adults. Diabetes Care 2014;37:963–969
por: Palmas, Walter, et al.
Publicado: (2015)

Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291–299
por: Lachin, John M., et al.
Publicado: (2020)

Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392–1398
por: He, Zebao, et al.
Publicado: (2020)

Response to Comment on Cefalu et al. The Alarming and Rising Costs of Diabetes and Prediabetes: A Call for Action! Diabetes Care 2014;37:3137–3138
por: Cefalu, William T., et al.
Publicado: (2015)

Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264
por: Sims, Emily K., et al.
Publicado: (2019)

Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Mezuk, Briana, et al.
Publicado: (2017)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Response to Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2018)

Response to Comments on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2017)

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Vistisen, Dorte, et al.
Publicado: (2021)

Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of “A+” Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637–2640
por: Mulukutla, Surya N., et al.
Publicado: (2019)

Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673–686
por: Taegtmeyer, Heinrich, et al.
Publicado: (2015)

Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631–1638
por: Galindo, Rodolfo J., et al.
Publicado: (2019)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2023)

Comment on Koivusalo et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care 2016;39:24–30
por: Bao, Wei
Publicado: (2016)

Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
por: Bůžková, Petra, et al.
Publicado: (2019)

Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526–532
por: Gregory, Justin M., et al.
Publicado: (2021)

Comment on Carrasco et al. Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells. Diabetes 2022;71:862–869
por: Memon, Bushra, et al.
Publicado: (2023)

Comment on Sato et al. Improving Type 2 Diabetes Through a Distinct Adrenergic Signaling Pathway Involving mTORC2 That Mediates Glucose Uptake in Skeletal Muscle. Diabetes 2014;63:4115–4129
por: Xiang, Lusha, et al.
Publicado: (2014)

Response to Comment on Elliott et al. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Diabetes Care 2019;42:1290–1296
por: Elliott, Michael D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k9kluk8fch3nkdccs0krh6ldgh